174 related articles for article (PubMed ID: 38369589)
1. TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association.
Liu XS; Chen YX; Wan HB; Wang YL; Wang YY; Gao Y; Wu LB; Pei ZJ
Sci Rep; 2024 Feb; 14(1):4042. PubMed ID: 38369589
[TBL] [Abstract][Full Text] [Related]
2. TRIP6, as a target of miR-7, regulates the proliferation and metastasis of colorectal cancer cells.
Ling Y; Cao C; Li S; Qiu M; Shen G; Chen Z; Yao F; Chen W
Biochem Biophys Res Commun; 2019 Jun; 514(1):231-238. PubMed ID: 31029422
[TBL] [Abstract][Full Text] [Related]
3. Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data.
Liu W; Luo X; Zhang Z; Chen Y; Dai Y; Deng J; Yang C; Liu H
Cancer Immunol Immunother; 2024 Mar; 73(4):69. PubMed ID: 38430268
[TBL] [Abstract][Full Text] [Related]
4. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
[TBL] [Abstract][Full Text] [Related]
5. TRIP6 regulates p27 KIP1 to promote tumorigenesis.
Lin VT; Lin VY; Lai YJ; Chen CS; Liu K; Lin WC; Lin FT
Mol Cell Biol; 2013 Apr; 33(7):1394-409. PubMed ID: 23339869
[TBL] [Abstract][Full Text] [Related]
6. TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity.
Lin VT; Lin FT
Cell Signal; 2011 Nov; 23(11):1691-7. PubMed ID: 21689746
[TBL] [Abstract][Full Text] [Related]
7. Characterization of TRIP6-dependent nasopharyngeal cancer cell migration.
Fei J; Li J; Shen S; Zhou W
Tumour Biol; 2013 Aug; 34(4):2329-35. PubMed ID: 23576104
[TBL] [Abstract][Full Text] [Related]
8. High Expression Level of TRIP6 is Correlated with Poor Prognosis in Colorectal Cancer and Promotes Tumor Cell Proliferation and Migration.
Ren H; Su Z; Yang J; Cao J; Zhang Y; Sheng K; Guo K; Wang Y
Biochem Genet; 2024 Mar; ():. PubMed ID: 38430448
[TBL] [Abstract][Full Text] [Related]
9. TRIP6 functions in brain ciliogenesis.
Shukla S; Haenold R; Urbánek P; Frappart L; Monajembashi S; Grigaravicius P; Nagel S; Min WK; Tapias A; Kassel O; Heuer H; Wang ZQ; Ploubidou A; Herrlich P
Nat Commun; 2021 Oct; 12(1):5887. PubMed ID: 34620853
[TBL] [Abstract][Full Text] [Related]
10. Defining the role of TRIP6 in cell physiology and cancer.
Willier S; Butt E; Richter GH; Burdach S; Grunewald TG
Biol Cell; 2011 Dec; 103(12):573-91. PubMed ID: 22054418
[TBL] [Abstract][Full Text] [Related]
11. TRIP6 promotes tumorigenic capability through regulating FOXC1 in hepatocellular carcinoma.
Wang F; Zhang B; Xu X; Zhu L; Zhu X
Pathol Res Pract; 2020 Apr; 216(4):152850. PubMed ID: 32046874
[TBL] [Abstract][Full Text] [Related]
12. TRIP6 accelerates the proliferation and invasion of cervical cancer by upregulating oncogenic YAP signaling.
Yang F; Li L; Zhang J; Zhang J; Yang L
Exp Cell Res; 2020 Nov; 396(1):112248. PubMed ID: 32853630
[TBL] [Abstract][Full Text] [Related]
13. The Zyxin-related protein thyroid receptor interacting protein 6 (TRIP6) is overexpressed in Ewing's sarcoma and promotes migration, invasion and cell growth.
Grunewald TG; Willier S; Janik D; Unland R; Reiss C; Prazeres da Costa O; Buch T; Dirksen U; Richter GH; Neff F; Burdach S; Butt E
Biol Cell; 2013 Nov; 105(11):535-47. PubMed ID: 24033704
[TBL] [Abstract][Full Text] [Related]
14. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.
Xu J; Lai YJ; Lin WC; Lin FT
J Biol Chem; 2004 Mar; 279(11):10459-68. PubMed ID: 14688263
[TBL] [Abstract][Full Text] [Related]
15. TRIP6, a novel molecular partner of the MAGI-1 scaffolding molecule, promotes invasiveness.
Chastre E; Abdessamad M; Kruglov A; Bruyneel E; Bracke M; Di Gioia Y; Beckerle MC; van Roy F; Kotelevets L
FASEB J; 2009 Mar; 23(3):916-28. PubMed ID: 19017743
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.
Miao X; Xu X; Wu Y; Zhu X; Chen X; Li C; Lu X; Chen Y; Liu Y; Huang J; Wang Y; He S
Tumour Biol; 2016 Jan; 37(1):1369-78. PubMed ID: 26298725
[TBL] [Abstract][Full Text] [Related]
17. TRIP6 regulates neural stem cell maintenance in the postnatal mammalian subventricular zone.
Lai YJ; Li MY; Yang CY; Huang KH; Tsai JC; Wang TW
Dev Dyn; 2014 Sep; 243(9):1130-42. PubMed ID: 25044744
[TBL] [Abstract][Full Text] [Related]
18. TRIP6 promotes cell proliferation in hepatocellular carcinoma via suppression of FOXO3a.
Zhao W; Dai Y; Dai T; Xie T; Su X; Li J; Zhou X; Meng K; Zhao X
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):594-601. PubMed ID: 29080747
[TBL] [Abstract][Full Text] [Related]
19. TRIP6 and LPP, but not Zyxin, are present at a subset of telomeres in human cells.
Sheppard SA; Savinova T; Loayza D
Cell Cycle; 2011 Jun; 10(11):1726-30. PubMed ID: 21519191
[TBL] [Abstract][Full Text] [Related]
20. Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.
Wang Y; Dong L; Liu Y
Cancer Biother Radiopharm; 2019 Oct; 34(8):529-536. PubMed ID: 31424277
[No Abstract] [Full Text] [Related]
[Next] [New Search]
